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Acute psychological stress activates the sympatho-adrenal medullary (SAM) system and 
hypothalamo-pituitary adrenal (HPA) axis. The relevance of this stress reactivity to long-term health 
and disease outcomes is of great importance. We examined prospective studies in apparently 
healthy adults to test the hypothesis that the magnitude of the response to acute psychological 
stress in healthy adults is related to future health and disease outcomes. 
Methods 
We searched Medline Complete, PsycINFO, CINAHL Complete and Embase up to 15 Aug 2019. 
Included studies were peer-reviewed, English-language, prospective studies in apparently healthy 
adults. The exposure was acute psychological stress reactivity (SAM system or HPA axis) at baseline. 
The outcome was any health or disease outcome at follow-up after ≥ 1 year. 
Results 
We identified 1,719 papers through database searching and 1 additional paper through other 
sources. Forty-seven papers met our criteria including 32,866 participants (range 30 – 4100) with 1-
23 years of follow-up. Overall, one third (32%; 83/263) of all reported findings were significant and 
two thirds (68%; 180/263) were null. With regard to the significant findings, both exaggerated (i.e. 
high) and blunted (i.e. low) stress reactivity of both the SAM system and the HPA axis at baseline 
were related to health and disease outcomes at follow-up. Exaggerated stress reactivity at baseline 
predicted an increase in risk factors for cardiovascular disease and decreased telomere length at 
follow-up. In contrast, blunted stress reactivity predicted future increased adiposity and obesity, 
more depression, anxiety and PTSD symptoms, greater illness frequency, musculoskeletal pain and 
regulatory T-Cell percentage, poorer cognitive ability, poorer self-reported health and physical 
disability and lower bone mass. 
Conclusion 
Exaggerated and blunted SAM system and HPA axis stress reactivity predicted distinct physical and 
mental health and disease outcomes over time. Results from prospective studies consistently 
indicate stress reactivity as a predictor for future health and disease outcomes. Dysregulation of 
stress reactivity may represent a mechanism by which psychological stress contributes to the 
development of future health and disease outcomes. 
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When we are exposed to acute stress, two main physiological systems are activated. The nervous 
system responds immediately via activation of the sympatho-adrenal medullary (SAM) system with 
consequent release of the catecholamines, adrenaline and noradrenaline, which in turn stimulate 
increases in heart rate (HR) and blood pressure (BP) (Chrousos, 2009). Activation of the SAM system 
is also reflected in elevation of salivary alpha-amylase levels (Skoluda et al., 2017; Strahler et al., 
2017). The endocrine system also responds to acute stress via activation of the hypothalamo-
pituitary adrenal (HPA) axis with consequent release of cortisol from the adrenal cortex (Chrousos, 
2009). Activation of both systems is integral to our response to stress in order to prepare the body 
to deal with the threat encountered and return the body to a steady state once the threat has 
passed. In contrast to physical stressors, responses to acute psychological stressors (to active-coping 
stressors) are considered “metabolically unjustified”, since fuel stores within the body are mobilised 
for activity that does not eventuate (Obrist, 1976). These metabolically unjustified responses in 
particular may have consequences for pathological states (Obrist, 1976). 
For decades, researchers and clinicians have been interested in whether the magnitude of the 
response to acute psychological stress is related to health and disease outcomes, with many 
researchers worldwide committing copious time and resources to measuring psychological stress 
reactivity to better characterise responses to stress. Indeed, a Web of Science search for the phrase 
“psychological stress reactivity” reveals a large increase in papers published in this field across the 
last two decades: 131 in 1998, 258 in 2008 and 430 in 2018. To provide context for the significance 
of findings from such studies (especially from cross-sectional studies, from which causation cannot 
be determined (Greenhalgh, 1997)), it is essential to understand how acute psychological stress 
reactivity is related to future physical and mental health and disease outcomes. Despite there being 
a broad base of research activity in this field, the relevance of psychological stress reactivity to long-
term physical and mental health and disease outcomes remains an emergent and hotly studied topic 
(Brindle et al., 2016; Ronaldson et al., 2016; Zhu et al., 2016; Carroll et al., 2017; Steptoe et al., 
2017).  
As early as 1981, it was proposed that high cardiovascular responses during acute psychological 
stressors (active-coping stressors) might reflect a high degree of susceptibility to later hypertension 
(Light, 1981; Obrist, 1981). Much work has tested this “reactivity hypothesis” and reviews (Krantz 
and Manuck, 1984; Cinciripini, 1986; Light, 1987; Steptoe, 2000; Taylor et al., 2003; Treiber et al., 
2003; Phillips and Hughes, 2011) and meta-analyses (Gasperin et al., 2009; Chida and Steptoe, 2010) 
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have been published showing support for this hypothesis. Nevertheless, the reactivity hypothesis, as 
originally stated, has a narrow focus on exaggerated cardiovascular reactivity and cardiovascular 
disease outcomes. Many questions remain unanswered and gaps remain in our understanding of 
this topic: for example, is parallel reactivity of non-cardiovascular measures important for health 
(e.g. catecholamines, salivary alpha-amylase, cortisol)?  Is blunted reactivity also related to future 
physical and mental health and disease outcomes?  Can health and disease outcomes other than 
cardiovascular disease also be related to earlier psychological stress reactivity (e.g. physical and 
mental health and disease outcomes)? 
While much of the early work in this field focussed on exaggerated reactivity, more recent studies 
have also considered the role of blunted reactivity in future health and disease outcomes, including 
outcomes that extend beyond cardiovascular disease (Carroll et al., 2017). As evidence in this field 
accumulates, disparate findings are spread across the literature of many different disciplines and 
disease states, meaning that findings in some fields may go unnoticed in other fields despite their 
potential relevance. Previous systematic syntheses of this evidence have focussed solely on 
cardiovascular reactivity (Gasperin et al., 2009; Chida and Steptoe, 2010) or on findings from specific 
data sets (Carroll et al., 2017). With so many unanswered questions remaining, a broad systematic 
review of findings in this field is warranted. 
We have taken a very broad approach to synthesising the current evidence in this field. Our 
overarching aim was to review prospective evidence examining how reactivity to psychological stress 
in healthy adults is related to future health and disease outcomes. We tested the hypothesis that the 
magnitude (both exaggerated and blunted) of the response to acute psychological stress (both SAM 
system and HPA axis) in healthy adults is related to future health and disease outcomes (both 
physical and mental). Since studies using prospective designs comprise a stronger form of evidence 










2.1 Search Strategy 
This review was undertaken in accordance with the Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses (PRISMA) Statement (Moher et al., 2009). The review protocol was 
registered with PROSPERO on 19 Dec 2017 (Registration ID CRD42017084161). The PICO framework, 
which describes participants, interventions, comparisons and outcomes was utilised to help develop 
the research question and search strategy (Moher et al., 2009). A systematic search was conducted 
by one author (AIT) in Medline Complete, PsycINFO and CINAHL Complete (all via Ebscohost) and 
Embase databases to locate peer-reviewed journal articles published up until 15 Aug 2019. Search 
terms included psychological stress AND (cortisol OR adrenaline OR noradrenaline OR salivary alpha-
amylase OR HR OR BP) AND reactivity AND longitudinal and related terms. Full search strategies 
including all search terms are available in supplementary material. If studies from our primary search 
alerted us to other relevant studies, these were included if they also met our criteria.  
2.2 Study inclusion and exclusion criteria 
Included studies were conducted in apparently healthy adult populations. They were observational, 
prospective, population-based cohort studies. As indicated in Figure 1, included studies imposed an 
acute psychological stressor at baseline and measured reactivity of one or more of the following 
variables: systolic BP (SBP), diastolic BP (DBP), HR, adrenaline, noradrenaline, salivary alpha-amylase 
and cortisol. These studies then followed-up the same participants after one year or longer and 
measured any outcome related to physical or mental health or disease.  
Studies were excluded if they were written in a language other than English, if they were non-peer 
reviewed publications (e.g. theses and conference abstracts) or if they were not original research 
articles (e.g. reviews, meta-analyses and protocol papers). Animal studies were excluded, as were 
studies conducted in children or adolescents (i.e. participants were <18 years old at baseline), 
pregnant women or in women who were peri-parturient or lactating. Studies were included if 
recruitment of apparently healthy individuals occurred via a workplace or particular occupation (e.g. 
public servants, military recruits), but not if participants were selected for inclusion because of a pre-
existing health or disease condition (e.g. borderline hypertension, depression or individuals 
recovering from substance abuse). If studies recruited using a population-based cohort approach 
and the sample included some individuals with a pre-existing condition at baseline (e.g. 
hypertension), these studies were included as long as there was no oversampling or special selection 
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for individuals with the condition and those present were there because of the natural presence of 
that condition in the population. Studies investigating psychological stress reactivity were included, 
while those investigating only physical stress reactivity were excluded (e.g. cold pressor test or 
handgrip test). Studies were excluded if reactivity to acute psychological stress at baseline was not 
considered alone, but only in combination with other variables (e.g. in combination with job 
demands or physical stressors). This review focused on SAM system (SBP, DBP, HR, adrenaline, 
noradrenaline and/or salivary alpha-amylase) and HPA axis (cortisol) responses to stress. Studies 
investigating only reactivity of other factors released during stress (e.g. cytokines) were beyond the 
scope of this review and were excluded.  
2.3 Screening, data extraction and assessment of study quality and risk of bias 
Search results were first imported into Endnote (X8, Clarivate Analytics, Philadelphia, USA), where 
duplicates were removed. To identify studies for inclusion, title and abstract screening and full-text 
screening were undertaken independently by two authors (AIT and SJH) using the Rayyan software 
platform (Ouzzani et al., 2016). Discrepancies were resolved by discussion and consensus. If 
discrepancies had remained, input from a third party would have been sought, but this was not 
necessary. For included studies, data extraction and assessment of quality and bias were undertaken 
independently by two parties (AIT and NS/AJC) after first pilot testing our draft data extraction 
spreadsheet using five studies selected from our included set. Discrepancies were resolved by 
discussion and consensus. If discrepancies had remained, input from a third party would have been 
sought, but this was not necessary.  
For each study, we extracted study author names, year of publication, country in which the study 
took place, number and sex of participants included in prospective analyses, age at baseline, name 
of cohort study (if relevant), type of acute psychological stressor imposed at baseline, stress 
reactivity variables measured at baseline (including sample times and method of reactivity 
calculation for cortisol), length of follow-up, physical and/or mental health and/or disease variables 
measured at follow-up and reported study findings (significant and null) relevant to the objectives of 
our review. Where studies included findings not relevant to the objectives of our review (e.g. cross-
sectional analyses, physical stressors, cytokine reactivity, stress recovery findings), these data were 
not extracted. 
Quality and risk of bias for each study were assessed by one author (AIT) using a modified version of 
the Cochrane Tool to Assess Risk of Bias in Cohort Studies (Cochrane, London, UK). Our assessment 
utilised the following questions: i) Can we be confident in the assessment of exposure? ii) Can we be 
confident in the assessment of outcome? iii) Can we be confident that the outcome of interest was 
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not present at start of study? iv) Can we be confident in the assessment of the presence or absence 
of relevant confounders? v) Was the follow up of cohorts adequate? Answer options were: 
“Definitely yes”, “Probably yes”, “Probably no” and “Definitely no”, which were allocated numerical 
values of 4, 3, 2 and 1, respectively. One further question was asked: vi) Was there evidence of any 
other sources of bias in reporting? Answer options were: “no”, “possibly” or “yes”. 
2.4 Synthesis of results 
Synthesis of study findings was achieved by calculating the total number of significant and null 
findings and by summarising and drawing together the main significant findings of the studies in a 
tabular form under the headings exaggerated reactivity and blunted reactivity for each of the SAM 
system and the HPA axis. Study quality and risk of bias were considered at an individual study level 
and an overall level in the appraisal of study outcomes. Due to the vast number of different 
exposure variables (SBP, DBP, HR, adrenaline, noradrenaline, salivary alpha-amylase and/or cortisol) 
and outcome variables (any measure of health or disease outcome was acceptable), meta-analysis 
was not appropriate and would not be meaningful. 
 
  




3.1 Study selection 
Our primary searches yielded 1,719 studies and we identified one additional study (Zhu et al., 2016) 
via our included studies (Figure 2). The paper by Zhu and colleagues (2016) was not identified in our 
primary search as the search terms “prospective”, “longitudinal” and “follow-up” did not appear in 
the title or abstract, nor was the study categorised under database assigned subject headings such 
as “Prospective Studies”, "Longitudinal Studies" or "Follow-Up Studies". After removal of duplicates 
(n = 565), 1,155 studies were screened by title and abstract and full-text articles were retrieved and 
screened for 80 studies. Thirty-three full-text articles did not meet our inclusion and/or exclusion 
criteria (see Figure 2 for details) and were excluded leaving 47 studies that were included in our 
systematic review.  
3.2 Characteristics of included studies including assessment of quality and risk of bias 
Table 1 shows the study details, study characteristics, significant and null findings and assessment of 
quality and risk of bias for each of the 47 included studies. Prospective studies in this field have been 
published over the last 25 years (1992 - 2017) at an average rate of 1.9 per year. The first SAM 
system study was published in 1992, while the first HPA axis study was published in 2012. Thirty-nine 
studies have investigated reactivity of the SAM system alone, six have investigated reactivity of the 
HPA axis alone and two have investigated reactivity of both systems within the same study. The total 
number of participants across the 47 included studies was 32,866 and the mean (±SD) number per 
study was 699 ± 921 (range 30 – 4100; median = 411). The mean (±SD) duration of follow-up was 6.4 
± 4.9 years (range 1 - 23 years; median = 5.0 years). Many large cohort studies are represented 
including the Whitehall II, CARDIA, West of Scotland Twenty-07 and Dutch Famine Birth Cohort 
studies (Table 1). Commonly studied psychological stressors have been used including mental 
arithmetic, video game, mirror image star-tracing task, structured interview, Raven’s matrices, 
anticipation of exercise, Stroop colour–word interference task, speech tasks and Trier Social Stress 
Test (TSST). A range of reactivity variables have been measured including SBP, DBP, mean arterial 
pressure (MAP), HR, adrenaline and noradrenaline from the SAM system and salivary cortisol and 
plasma cortisol from the HPA axis. None of the 47 included studies measured salivary alpha-amylase 
reactivity. Outcome measures have been many and varied including resting and ambulatory SBP and 
DBP, hypertensive status, carotid intima-media thickness (IMT), coronary artery calcification (CAC), 
body mass index (BMI), waist circumference, obesity status, telomere length, cognitive ability, 
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symptomology for depression, anxiety and post-traumatic stress disorder (PTSD), self-reported 
health, self-reported physical disability, musculoskeletal pain, regulatory T-Cell percentage and bone 
mineral content and density.  
Within individual studies, quality and risk of bias is variable with the full range of assessment 
response options (1-4) having been used (Table 1). For this body of work as a whole (i.e. across 
studies), study quality is generally high and risk of bias is generally low (Figure 3). The percentage of 
studies for which the answer was “Definitely yes” or “Probably yes” was 94% for “Can we be 
confident in the assessment of exposure?”; 94% for “Can we be confident in the assessment of 
outcome?”; 87% for “Can we be confident that the outcome of interest was not present at start of 
study?”; 94% for “Can we be confident in the assessment of the presence or absence of relevant 
confounders?”; and 87% for “Was the follow up of cohorts adequate?”  In answer to the question, 
“Was there evidence of any other sources of bias in reporting?”, 45 studies were deemed “no”, 2 
studies (Steptoe and Wardle, 2005; Senan and Petrosyan, 2014) were deemed “possibly” and none 
were deemed “yes”. While the stated objective of the study by Steptoe and Wardle (2005) was to 
investigate the influence of recovery (rather than reactivity) on adiposity measures over 3 years, the 
authors state that the extent to which reactivity predicts changes in BMI and waist-hip ratio (WHR) 
was also assessed. Therefore, the omission of results for the influence of reactivity on WHR change 
(see Table 1) may reflect reporting bias, but may instead reflect that these results were not deemed 
important to the stated objectives of the study. The paper by Senan and Petrosyan (2014) provides 
insufficient details to assess if there is reporting bias. For example, the paper does not include a 
description of the statistical analyses conducted. 
3.3 Synthesis of results  
Of the 47 studies included in this review, 39 (83%) reported one or more significant findings and 39 
(83%) reported one or more null findings (Table 1). Overall, one third (32%; 83/263) of reported 
findings were significant and two thirds (68%; 180/263) were null (Table 1). Significant findings are 
synthesised in Table 2. Both exaggerated and blunted reactivity of both the SAM system and HPA 
axis were related to future physical and mental health and disease outcomes. Overall, the pattern of 
significant vs null findings was not influenced by the type of stress task utilised, the duration of 
follow-up period or the timing of samples or method of calculating reactivity for cortisol.  
Exaggerated cardiovascular reactivity (mostly exaggerated SBP and DBP reactivity) was related to 
greater future resting and ambulatory SBP and DBP, risk of hypertension, earlier onset of 
hypertension, greater progression of IMT, odds of having CAC and increased risk of sudden coronary 
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death and death from any cause (Table 2). Exaggerated noradrenaline reactivity at baseline was 
related to greater waist circumference at follow-up.  
Exaggerated salivary cortisol reactivity was related to greater risk of hypertension and greater CAC 
progression (Table 2). Beyond cardiovascular outcomes, findings for exaggerated salivary cortisol 
reactivity at baseline also showed a relationship to shorter leukocyte telomeres at follow-up.  
Blunted cardiovascular reactivity (mostly blunted HR reactivity) was related to greater illness 
frequency, greater increases in resting DBP, greater odds of having CAC in blacks (but not whites), 
greater carotid IMT, greater incidence of obesity, poorer self-reported health and greater 
progression of self-reported physical disability, more symptoms for depression and anxiety and 
reduced cognitive ability (Table 2). Blunted adrenaline reactivity was related to greater BMI, waist 
circumference and triceps skin thickness. 
Blunted plasma cortisol reactivity was prospectively related to greater musculoskeletal pain in pain-
sensitive females (but not males) (Table 2). Blunted salivary cortisol was related to more PTSD 
symptomology after exposure to new-onset traumatic events, greater regulatory T-Cell percentage 
(which in turn, was associated with poorer physical and mental health and more depressive 
symptomatology) and lower bone mineral content and bone mineral density in males (but not 
females; Table 2). 
With regards to null findings, eight studies (17%) did not find any significant link between reactivity 
at baseline and health and disease outcomes at follow-up (Table 1). While there were no obvious 
differences overall in study quality or risk of bias across these vs studies with significant findings, 
each of these studies had individual limitations that might help explain null findings. Since Brody et 
al. (1996) measured MAP reactivity at baseline rather than SBP and DBP separately, it is not known if 
significant findings may have been present for either SBP or DBP alone. Fauvel et al. (2003) split 
participants into high-SBP-reactivity and non-high-SBP-reactivity groups with the cut-off between 
groups based on criteria unrelated to stress reactivity (based on the level of perceived job strain). 
Detailed results for linear multivariate analyses were not presented and, despite measuring DBP and 
HR reactivity at baseline, results for these variables are not reported (Fauvel et al., 2003). In the 
study by Steptoe and Marmot (2005), significant findings for reactivity did not survive adjustment for 
post-stress recovery, which was an absolute value, measured 40-45 min after the stressor. Since 
there was no significant change in BMI across the 3 year study by Steptoe and Wardle (2005), it is 
not surprising that reactivity did not predict BMI change, and as mentioned earlier, despite being 
measured, results for reactivity and change in WHR are missing from this paper. Despite rigorous 
methods in the study by Stewart et al. (2006), there was an unexpected but significant decrease in 
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resting SBP and DBP from baseline to follow-up (3.2 years). In light of this finding, it is not surprising 
that reactivity did not predict change in resting SBP or DBP. Flaa et al. (2008a) found that adrenaline 
and noradrenaline reactivity did not predict fasting glucose or HOMA-IR after 18 years of follow up, 
but it is not known if significant findings for SBP, DBP or HR reactivity may have been present, as 
these analyses were not conducted/reported (despite being measured at baseline (Flaa et al., 
2008b)). While Shaffer et al. (2012) found that SBP and DBP reactivity did not predict risk of incident 
CVD events during 10 years of follow-up, this study does not appear to have achieved reliable and 
consistent stress reactivity at baseline. Mean SBP reactivity (mean ± SD = 1.1 ± 11.0 mmHg) and DBP 
reactivity (mean ± SD = 2.2 ± 7.4 mmHg) were close to 0 mmHg with some individuals having large 
negative SBP reactivity (range = -39 to 48 mmHg) and DBP reactivity (range = -22 to 27 mmHg) in 
response to the stressor (Shaffer et al., 2012). Finally, while Gentile et al. (2015) found that SBP, DBP 
and HR reactivity did not predict metabolic burden (measured as the number of metabolic 
parameters for which participants were in the highest quartile; lowest for high-density lipoprotein 
cholesterol) or incident metabolic syndrome, it is not clear if blood sampling (for metabolic makers) 
may have interfered with reactivity measures. The timing and method of blood sample collection is 
not reported in relation to the timing of measurement of SBP, DBP and HR response to psychological 
stressors. 
It must also be noted that studies reporting significant findings often also reported a number of null 
findings (Table 1). Indeed, overall, more null findings (180/263; 68%) than significant findings 
(83/263; 32%) were reported. As an example, while SBP reactivity at baseline predicted resting SBP 
at follow-up (Carroll et al., 2001), DBP reactivity did not predict resting DBP and neither SBP nor DBP 
predicted hypertensive status at follow-up. In another example (Phillips et al., 2011a), while blunted 
HR reactivity at baseline predicted greater deterioration of physical function over the 5 years of 
follow-up, SBP and DBP reactivity did not predict change in disability score. In one final example (this 
time from the HPA axis), blunted salivary cortisol reactivity at baseline predicted lower BMD and 
BMC at follow-up in males, but not in females, and these findings did not extend to total plasma 
cortisol reactivity, which did not predict BMD or BMC at follow-up (Zhu et al., 2016). 
Effect sizes for significant findings were typically modest and consistent across different studies. HR 
reactivity to mental arithmetic accounted independently for 4% of the variance in resting SBP at 
follow-up in the study by Stewart and France (2001). In the study by Carroll et al. (2003), SBP and 
DBP reactivity at baseline predicted 5-year upward drift in resting SBP and DBP, respectively, 
accounting for 3.6% and 2.9% of variance, respectively, beyond traditional risk factors. Finally, 4.5% 
of the variance in PTSD symptomatology in soldiers who had experienced new-onset traumatic 
events was explained by salivary cortisol reactivity at baseline, with lower (blunted) reactivity 
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predicting greater increase in PTSD symptomatology (Steudte-Schmiedgen et al., 2015). Effect sizes 
were consistent across studies using different types of stress tasks, different reactivity variables and 
with varying outcomes investigated. There were no health or disease outcomes that were more 
prominent than others, based on effect sizes. 
  
Anne Turner et al. Page 14 
 
4. Discussion 
This systematic review presents a consistent line of prospective evidence that both exaggerated and 
blunted responses of both the SAM system and HPA axis to acute psychological stress in healthy 
adults are related to future physical and mental health and disease outcomes. One third of all 
reported findings linking stress reactivity at baseline to health and disease outcomes at follow-up 
were significant while two thirds were null. In relation to the significant findings, the reactivity 
hypothesis has proven to apply in a much broader context than originally proposed. The original 
reactivity hypothesis had a narrow focus on the relationship between exaggerated cardiovascular 
reactivity and future cardiovascular disease outcomes (Light, 1981; Obrist, 1981). Our systematic 
review provides substrate for a “bidirectional multi-system reactivity hypothesis” that the 
magnitude (both exaggerated and blunted) of the response to acute psychological stress (both SAM 
system and HPA axis) in healthy adults is related to future health and disease outcomes (both 
physical and mental). In relation to the null findings, a simple count of findings may provide a useful 
overview, but may also give an overly simplistic assessment of this field. In contrast, a detailed 
assessment of combinations of outcomes within and between studies may reveal a richness of 
information about underlying mechanisms and patterns of response that may be important in 
determining the relationship between reactivity to psychological stress and future health and 
disease outcomes. The specific outcomes reported in this field to date fall into several categories, 
which are considered in the following subsections (4.1 - 4.4). 
4.1 Cardiovascular disease risk factor outcomes 
In keeping with the original reactivity hypothesis, there is no surprise that individuals with elevated 
cardiovascular reactivity at baseline (SBP, DBP and/or HR) had more risk factors for cardiovascular 
disease at follow-up including greater resting and ambulatory SBP and DBP, more incident 
hypertension, earlier onset of hypertension, greater progression of IMT, greater risk of having CAC 
and increased risk for sudden coronary death (Table 2). Interestingly, three studies also reported 
that individuals with blunted HR reactivity had more risk factors for cardiovascular disease at follow-
up including greater increases in resting DBP (Brody and Rau, 1994), greater odds of having CAC in 
blacks (but not whites) (Matthews et al., 2006) and greater carotid IMT (Heponiemi et al., 2007). 
These findings expand the original reactivity hypothesis to implicate blunted as well as exaggerated 
reactivity in the pathogenesis of cardiovascular disease, thus, supporting an inverted-U model of the 
reactivity hypothesis in which exaggerated and blunted responses may be detrimental but 
intermediate responses may be the most adaptive and resilient responses (Carroll et al., 2017). Thus, 
the reactivity hypothesis has proven its utility in a bidirectional way, incorporating both exaggerated 
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and blunted stress reactivity in relation to future health and disease outcomes. It is noteworthy that 
HR was the reactivity variable in each case where blunted cardiovascular reactivity was related to 
future cardiovascular disease risk factors. These findings are in keeping with results of a cluster 
analysis by Brindle et al. (2016), whereby the cluster with the greatest risk for future hypertension 
was one in which SBP and DBP reactivity was exaggerated, but HR reactivity was relatively small. 
Since MAP is determined by changes in cardiac output and/or total peripheral resistance (i.e. MAP = 
cardiac output X total peripheral resistance), this may suggest maladaptation when MAP is elevated 
primarily via peripheral vasoconstriction rather than via elevation of cardiac output (Brindle et al., 
2016). Indeed, CAC was predicted by both exaggerated SBP reactivity and blunted HR reactivity (in 
blacks) within the same study (Matthews et al., 2006). The most adaptive responses may involve the 
elevation of MAP primarily via increases in cardiac output. These findings suggest that the 
combination or pattern of response variables may be important in relation to future health and 
disease outcomes. 
Keeping, for now, with cardiovascular disease risk factor outcomes, exaggerated cortisol reactivity at 
baseline was also implicated. Findings that exaggerated salivary cortisol reactivity predicted greater 
risk of hypertension (Hamer and Steptoe, 2012) and greater CAC progression (Hamer et al., 2012) 
effectively extend the reactivity hypothesis beyond just the SAM system to include the HPA axis, as 
well. These findings provide support for a multi-system reactivity hypothesis by providing evidence 
that stress reactivity of multiple stress response systems (SAM system and HPA axis) is related to 
future health and disease outcomes. There are known to be bidirectional stimulatory connections 
between the HPA axis control centre in the hypothalamus and the SAM system control centre in the 
brainstem, such that activation of either one of these systems results in activation of the other 
(Chrousos, 2009). Consequently, it is tempting to speculate that individuals with exaggerated SAM 
system reactivity may be those who also display exaggerated HPA axis reactivity. However, the 
findings of Hamer et al. (2012) do not support this supposition. While salivary cortisol reactivity at 
baseline predicted CAC progression, SBP and DBP reactivity at baseline in the same participants did 
not predict CAC progression at follow-up. No other prospective studies have measured both cortisol 
reactivity and cardiovascular reactivity together in the same study in relation to cardiovascular 
disease outcomes. 
4.2 Adiposity outcomes 
Findings for adiposity outcomes are interesting. The greatest weight of evidence shows that blunted 
reactivity is related to accumulation of adipose tissue over time. For example, two studies found 
that, after adjusting for a range of possible confounders including baseline obesity status, blunted 
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HR reactivity predicted greater future likelihood of being obese (Carroll et al., 2008; Phillips et al., 
2012). Furthermore, blunted adrenaline reactivity was related to greater future BMI, waist 
circumference and triceps skinfold thickness (Flaa et al., 2008c). Nevertheless, further findings from 
this latter study showed that exaggerated noradrenaline reactivity was also related to greater waist 
circumference in the same participants (Flaa et al., 2008c). In other words, greater waist 
circumference at follow-up was predicted by both blunted adrenaline reactivity and exaggerated 
noradrenaline reactivity in the same participants. Since adrenaline has a slightly greater effect on the 
heart (via beta-adrenergic receptors) and noradrenaline on peripheral vasoconstriction (via alpha-
adrenergic receptors) (Brunton et al., 2018), this profile of reactivity responses aligns with the 
exaggerated blood pressure and blunted heart rate profile described earlier. Thus, these findings 
provide further support for the notion that the pattern of response is important in relation to future 
health and disease outcomes. These findings also provide further support for an inverted-U model of 
the reactivity hypothesis, in which exaggerated and blunted responses may be detrimental, but 
intermediate responses may be the healthiest responses (Carroll et al., 2017). In the only study to 
measure cortisol reactivity in relation to future adiposity (Phillips et al., 2012), no relationship to 
future adiposity was found. 
4.3 Self-report, mental health and cognitive outcomes 
Self-report, mental health and cognitive outcomes were always predicted by blunted as opposed to 
exaggerated reactivity. Blunted cardiovascular reactivity predicted poorer outcomes for self-
reported illness frequency (Lawler and Schmied, 1992), self-reported health (Phillips et al., 2009), 
progression of self-reported physical disability (Phillips et al., 2011a), more depression symptoms 
(Phillips et al., 2011b), more anxiety symptoms (Yuenyongchaiwat and Sheffield, 2017) and poorer 
cognitive ability (Ginty et al., 2011; Yuichiro et al., 2016). Blunted HPA axis reactivity was also 
implicated, with blunted salivary cortisol reactivity predicting more PTSD symptomology in male 
soldiers following exposure to new-onset traumatic events during military deployment to 
Afghanistan (Steudte-Schmiedgen et al., 2015). Collectively, these behavioural, mental health and 
cognitive findings provide support for a compelling argument proposed by Carroll et al. (2017) that 
blunted reactivity of the stress systems may reflect dysregulation of the motivational systems within 
the brain.  
4.4 Other outcomes 
Several other disparate outcomes were also related to baseline levels of HPA axis reactivity (both 
exaggerated and blunted). Exaggerated cortisol reactivity predicted telomere attrition (Steptoe et 
al., 2017), whereas blunted cortisol reactivity predicted musculoskeletal pain in pain-sensitive 
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females (Paananen et al., 2015), regulatory T-cell percentage, which in turn was related to poorer 
physical and mental health and more depressive symptomatology (Ronaldson et al., 2016), and 
lower bone mineral content and density in males (Zhu et al., 2016). Interestingly, in the study by Zhu 
et al. (2016), salivary cortisol but not total plasma cortisol predicted lower BMC and BMD in males. 
This discrepancy may have occurred because the study was better powered for salivary cortisol 
measures, with more of the participants in the study providing samples for salivary cortisol 
measurement (n=801; 390 females and 411 males) compared with plasma cortisol measurement 
(n=648; 291 females and 357 males). Alternatively, the discrepancy between salivary cortisol and 
total plasma cortisol findings may reflect underlying differences in the sensitivity of these measures 
in detecting dynamic activity of the HPA axis (Zhu et al., 2016). Since salivary cortisol represents the 
free fraction of circulating cortisol (i.e. that fraction which is not attached to a binding protein), it is 
thought to be a more sensitive measure of dynamic HPA axis activity (Kirschbaum and Hellhammer, 
1994; Gozansky et al., 2005). The major plasma binding protein for cortisol (corticosteroid-binding 
globulin; CBG) is known to vary widely within and between individuals and has been shown to 
complicate the interpretation of dynamic assessment of HPA axis activity as measured by total 
plasma cortisol (Dhillo et al., 2002). Salivary cortisol collection has the added advantage of being 
minimally invasive compared with plasma cortisol collection. Nevertheless, despite salivary cortisol 
being a more sensitive measure of dynamic HPA axis activity, Paananen et al. (2015) found total 
plasma cortisol to be a significant predictor of musculoskeletal pain in pain-sensitive females, 
perhaps reflecting a greater effect size for this outcome. Salivary cortisol was not measured in this 
study (Paananen et al., 2015). None of these disparate studies of cortisol reactivity included any 
measures of SAM system reactivity. 
4.5 Implications of significant findings 
Collectively, these significant findings support a “bidirectional multi-system reactivity hypothesis”. 
We have shown that a diverse range of physical and mental health outcomes are predicted by both 
exaggerated and blunted responses of the SAM system and the HPA axis to acute psychological 
stress. Healthy adaptive stress responses appear to be intermediate or “Goldilocks” stress 
responses: Not too large and not too small (Figure 4). While we cannot conclude causation from 
prospective cohort studies, the temporal sequence of these studies, with exposure preceding 
outcome, provides a stronger form of evidence towards potential causality compared with cross-
sectional studies in which the exposure and outcome coincide (Greenhalgh, 1997). Indeed, many 
authors have speculated that stress reactivity may be a mechanism or possible causal factor by 
which psychological stress contributes to health and disease outcomes (Flaa et al., 2008b; Hamer et 
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al., 2012; Hamer and Steptoe, 2012; Steptoe et al., 2016; Yuenyongchaiwat, 2017). Consequently, 
the role of stress reactivity in future health and disease outcomes deserves further consideration. 
The pattern of response may be an important factor in the link between stress reactivity and future 
health and disease outcomes. For the SAM system, exaggerated blood pressure reactivity combined 
with blunted cardiac reactivity appears to be emerging as a maladaptive response. While the 
combination of responses between the SAM system and HPA axis may also be important, relatively 
fewer studies have considered the HPA axis and only two have considered reactivity of both systems 
in the same participants within the same study (Hamer et al., 2012; Phillips et al., 2012). 
Nevertheless, there appears to be some consistency in outcomes across these two systems as both 
exaggerated SAM system and exaggerated HPA axis reactivity predicted cardiovascular risk factor 
outcomes and both blunted SAM system reactivity and blunted HPA axis reactivity predicted mental 
health symptomology (Table 2). Further consideration of the role of response patterns is warranted. 
Given the findings of consistent links between stress reactivity and future health and disease 
outcomes, it is tempting to contemplate the utility of stress reactivity as a clinical screening tool for 
early diagnosis of exaggerated or blunted reactivity to facilitate identification of individuals for 
targeted intervention. Nevertheless, this eventuality seems unlikely. A barrier to the use of stress 
reactivity as a clinical screening tool is our lack of reference values for the magnitude of stress 
reactivity that is linked to future adverse health and disease outcomes. Furthermore, the 
development of reference values for stress reactivity would seem difficult at best given the vast 
array of methodological differences utilised in this body of research. Research conducted to date has 
used many different stressors, many different reactivity variables (SBP, DBP, MAP, HR, adrenaline, 
noradrenaline and cortisol) and many different sampling protocols with no standardisation of the 
number or timing of measures taken. Different ways of calculating reactivity have also been used. 
For cortisol, best-practice recommendations for calculating reactivity are available (Miller et al., 
2018), but consideration may also need to be given to the ultradian rhythmicity of cortisol (Henley et 
al., 2009; Lightman and Conway-Campbell, 2010) and the debate around the classification of 
responders versus non-responders (Miller et al., 2013). Consensus agreement on best-practice 
methodologies for measuring stress reactivity would be needed, as well as an increase in the 
number of studies that measure multiple stress systems in the same participants within the same 
studies.  
Effect sizes found in this review have generally been modest and consistent across studies indicating 
that stress reactivity offers relatively low levels of independent prediction of health and disease 
outcomes beyond other (traditional) risk factors and covariates. Nevertheless, reactivity to 
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psychological stress may represent a modifiable risk factor, whereas some other traditional health 
and disease risk factors and covariates are not modifiable (e.g. age and sex). If reactivity to 
psychological stress is a causal component in the aetiology of disease, these findings support a role 
for programs aimed at reducing stress reactivity such as stress management in daily life (e.g. physical 
activity, mindfulness and/or nature relatedness programs). Since the link between stress reactivity at 
baseline and health and disease outcomes at follow-up is similar across different types of outcomes, 
stress management programs may have equal benefits across multiple dimensions of health and 
disease. 
4.6 Implications of null findings 
In relation to the null findings, it is interesting to note that overall, null findings outnumbered 
significant findings two to one. While this summary statistic helps to give an overall indication of the 
state of this field, a simple count of findings may also give an overly simplistic assessment. In many 
cases, null findings showed a trend towards being significant (P = 0.05 - 0.1) and/or represented 
significant findings that did not survive adjustment for covariates. A detailed assessment of 
combinations of outcomes within and between studies instead reveals a richness of information 
about underlying mechanisms and patterns of response that may be important in determining the 
relationship between reactivity to psychological stress and future health and disease outcomes. For 
example, that SBP but not DBP or HR reactivity predicted IMT (Jennings et al., 2004) may indicate 
nuances of underlying physiological mechanisms at play rather than simply a lack of utility of DBP 
and HR reactivity as predictive factors. Similarly, that blunted DBP and HR but not SBP reactivity 
predicted poorer self-reported health at follow-up (Phillips et al., 2009) might point towards 
mechanisms at play rather than a simple lack of utility of SBP as a predictive factor for this outcome. 
For cortisol, the prediction of BMD and BMC by blunted salivary but not plasma cortisol reactivity 
(Zhu et al., 2016) may be an informative methodological consideration rather than being a useful 
contribution to an overall summary statistic. 
4.7 Strengths and limitations 
Given the maturity of this field, we have been able to limit our review to prospective evidence. This 
is a strength of our review. Prospective studies provide a stronger form of evidence than cross-
sectional studies because of the temporal sequence between exposure and outcome (Greenhalgh, 
1997) (i.e. reactivity is measured at baseline, before any health or disease outcomes emerge and are 
measured at follow-up). In keeping with best practice, most studies included in this review adjusted 
for baseline levels of outcome variables to ensure that the outcome variable of interest was not 
present at the start of the study. Indeed, for 87% of studies, we answered “Definitely yes” or 
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“Probably yes” for “Can we be confident that the outcome of interest was not present at start of 
study?” 
Even though our search of the literature and our synthesis of findings have been systematic, our 
conclusions may be limited if publication bias exists in the field. Researchers and journals may be 
more likely to publish studies reporting significant findings compared with null findings. Indeed, 
some included studies have reported investigating variables for which no findings are reported 
(Matthews et al., 1993; Fauvel et al., 2003; Steptoe and Wardle, 2005; Deter et al., 2006; Carroll et 
al., 2008; Phillips et al., 2012; Yuenyongchaiwat et al., 2015; Yuenyongchaiwat, 2017) (see Table 1). It 
is not clear why such findings were omitted. Perhaps a priori decisions were made about which 
exposure/outcome combinations were most important to investigate. Alternatively, if findings were 
null, perhaps there was a perception that such findings were less important to report or perhaps 
journal space limitations precluded reporting of null findings. 
The consideration of and adjustment for potential confounding factors was undertaken in most 
included studies. Indeed, for 94% of studies, we answered “Definitely yes” or “Probably yes” for 
“Can we be confident in the assessment of the presence or absence of relevant confounders?” 
Nevertheless, it is possible that there is residual confounding by unmeasured confounding variables 
in this body of work. A potential confounding variable that deserves investigation in future studies is 
early life adversity (Bunea et al., 2017; Lovallo et al., 2017), which may influence both our exposure 
variable (stress reactivity) and our outcome measures (health and disease outcomes). 
4.8 Future directions 
There are a number of key future directions that would be beneficial for this field going forward: 
Firstly, given the bidirectional stimulatory connections between the SAM system and HPA axis 
(Chrousos, 2009) and the emerging importance of the pattern of reactivity response variables, it 
would be beneficial for further studies to consider reactivity of multiple stress systems within the 
same study. Only two studies in the current review measured both SAM system and HPA axis 
reactivity within the same study (Hamer et al., 2012; Phillips et al., 2012). Consideration of the 
patterns of response of reactivity variables both within the SAM system and across this and the HPA 
axis may reveal important further insights regarding the role of stress reactivity in future health and 
disease outcomes.  
Secondly, while it was beyond the scope of the current review, reactivity of the immune system to 
acute psychological stress may represent an important additional pathway for investigation. 
Systemic inflammatory markers are known to increase in response to acute psychological stress 
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(Rohleder, 2014), with several studies implicating reactivity of inflammatory markers in future health 
and disease outcomes (Brydon and Steptoe, 2005; Ronaldson et al., 2016; Steptoe et al., 2016).  
Thirdly, in addition to patterns of individual response variables, consideration of the integrated 
response of the stress pathways may also be enlightening. Some work has considered the integrated 
response of the SAM system and the HPA axis by measuring the ratio of the response of these two 
systems (Ali and Pruessner, 2012) and this approach may prove valuable in advancing this field in 
future studies.  
Fourthly, to broaden our understanding of the range of outcome measures linked to stress 
reactivity, opportunities may exist for further hypothesis testing using existing data sets where 
reactivity has been measured at baseline. Indeed, there may be great scope to expand our 
understanding in this field further using existing data sets. 
Lastly, in light of the findings of this review, further systematic syntheses would also help advance 
our understanding of underlying mechanisms in this field: 
• It would be beneficial to consider the characteristics of individuals that determine the 
magnitude of their response to acute psychological stress. A systematic synthesis of existing 
research could consider factors such as genetic variation (e.g. Wust et al. (2004)), early life 
adversity (e.g. Bunea et al. (2017)) and levels of adiposity (e.g. Jones et al. (2012)) and 
physical activity (e.g. Mucke et al. (2018)).  
• Another natural extension of this research is to determine whether the magnitude of the 
response to acute psychological stress can be modified using interventions aimed at 
improving certain aspects of lifestyle behaviours such as mindfulness interventions (e.g. 
Lindsay et al. (2018)), dietary interventions (e.g. West et al. (2012)) and exercise 
interventions (e.g. Throne et al. (2000)). A systematic synthesis of existing research on this 
topic would be valuable. 
 
5. Conclusions 
This systematic review provides substrate for a “bidirectional multi-system reactivity hypothesis” 
that the magnitude (both exaggerated and blunted) of the response to acute psychological stress 
(both SAM system and HPA axis) in healthy adults is related to future health and disease outcomes 
(both physical and mental). Our findings provide support for an inverted-U model of the reactivity 
hypothesis in which exaggerated and blunted responses may be detrimental, but intermediate 
responses, “Goldilocks” responses, may be the most adaptive and resilient responses. Our findings 
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also provide support for the notion that the pattern of individual response variables may be 
important to the link with future health and disease outcomes. In future research, this field would 
benefit from considering multiple stress system pathways and response patterns in relation to stress 
reactivity and additional health and disease outcomes. It will also be beneficial to consider factors 
that determine the magnitude of stress reactivity and whether interventions aimed at improving 
lifestyle behaviours can improve stress reactivity. If stress reactivity is a mechanism through which 
psychological stress contributes to the development of future health and disease outcomes, these 
findings provide support for the benefits of stress management programs. 
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Figure 1. Schematic representation of systematic review criteria illustrating a typical reactivity 
response. Included studies imposed an acute psychological stressor at baseline and measured 
reactivity of one or more of systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate 
(HR), adrenaline, noradrenaline, salivary alpha-amylase (sAA) and/or cortisol. The same participants 
were then followed-up after one year or longer for the measurement of any physical or mental 

















































Records identified through 
database searching 
(n = 1,719) 
Additional records identified 
through other sources 
(n = 1) 
Records after duplicates 
removed (n = 1,155) 
Records screened by title 
and abstract (n = 1,155) 
Records excluded 
(n = 1,075) 
Full-text articles assessed 
for eligibility (n = 80) 
Full-text articles excluded, with 
reasons (n = 33) 
n = 2 non-English 
n = 4 review, conference abstract 
n = 9 non-healthy population 
n = 5 children/adolescents 
n = 10 psychological stress reactivity 
not considered or not considered alone 
n = 1 follow-up < 1 year 
n = 2 cross-sectional analyses only 
 
Studies included in final 
synthesis (n = 47) 
Duplicates removed 
(n = 565) 



















Figure 4. A schematic representation of the Goldilocks stress response. The Goldilocks stress 
response, represented by the solid/blue line, is an intermediate stress response. It is not too large 
(exaggerated) and not too small (blunted). Evidence presented in this review shows that it is the 
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Table 1. Characteristics of studies included in systematic review (n = 47). Study numbers are defined in Table 1 for use in in Table 2. 
No. Authors, year, 
country in which 
study took place 
Participants (N, 
sex, age at 
baselinea), name 
of cohort study, 
if relevant 














(number of significant 
findings reported) 
Null findings 
(number of null 
findings reported) 
Study quality, 
risk of bias 
assessment, 
i, ii, iii, iv, v, vid 
1 Lawler and 
Schmied (1992) 
USA 
32 F,  
43.8 (27 - 64) y 
Structured 
interview 
SBP, DBP, HR 5 y Frequency and 
severity of illness in 
past 12 months 
 
Blunted SBP reactivity 





SBP reactivity did not 
predict illness 
severity;  
DBP and HR reactivity 
did not predict illness 
outcomes 
(5) 
4, 4, 4, 4, 2, n 
2 Light et al. (1992) 
USA 
30 M,  
19.9 ± 1.3 y 
Reaction time 
task with threat 
of shock (no 
shock was 
delivered) 
SBP, DBP, HR 10-15 y 
 
Resting SBP, DBP  SBP reactivity at 
baseline predicted 
resting SBP at follow-
up; 
DBP and HR reactivity 
at baseline predicted 
resting DBP at follow-
up 
(3) 
DBP, HR reactivity at 
baseline did not 




4, 4, 4, 4, 2, n 
3 Matthews et al. 
(1993) 
USA 
106 F,   
41.8 ± 5.3 y  
76 M,  
44.1 ± 6.5 y 
Mental arithmetic 
and mirror tracing 
tasks 
SBP, DBP, HR 6.5 ± 0.5 y Resting SBP, DBP, 
HR 
DBP reactivity to 
mental arithmetic and 
mirror tracing at 
baseline predicted 
resting DBP at follow-
up, as did SBP 
reactivity to mental 
arithmetic 
(3) 
SBP reactivity to 
mirror tracing did not 
predict resting DBP at 
follow-up (P<0.10); 
SBP reactivity to 
mental arithmetic did 
not predict resting 
SBP at follow-up 
(P<0.07); 
No results are 
reported for HR 
reactivity at baseline 
or resting HR at 
follow-up 
(2) 
4, 4, 4, 4, 3, n 
4 Brody and Rau 
(1994) 
34 F, 46 M,  
31.4 ± 6.0 y 
Mental 
arithmetice 
SBP, DBP, HR 1.6 y Resting SBP, DBP Blunted HR reactivity 
at baseline predicted 
SBP, DBP, HR 
reactivity at baseline 
2, 4, 4, 2, 3, n 
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Germany greater increase in 
resting DBP from 
baseline to follow-up 
(1) 
did not predict change 
in resting SBP from 
baseline to follow-up 
(3) 
5 Carroll et al. 
(1995) 
England 
1003 M,  
44.1 ± 5.9 y, 
Whitehall II 
Mental stress task 
(Raven's 
matrices) 
SBP, DBP 4.9 ± 0.5 y Resting SBP, DBP SBP reactivity at 
baseline predicted 
resting SBP at follow-
up;  
DBP reactivity at 
baseline predicted 
resting DBP at follow-
up  
(2) 
 (0) 4, 3, 4, 3, 3, n 




27.0 ± 6.5 y  
47 M, 
27.9 ± 6.2 y 
Mental arithmetic MAP, HR 4 y Resting MAP (0) MAP and HR reactivity 
at baseline did not 
predict change in 
resting MAP from 
baseline to follow-up 
(2) 
3, 3, 4, 4, 3, n 








Anticipation of an 
exercise  
SBP, DBP 4.1 y  
(2.3 - 5.2 y) 
Hypertensive status SBP and DBP reactivity 





(0) 4, 3, 4, 4, 3, n 
8 Markovitz et al. 
(1998) 
USA 
1776 F, 1588 M, 
27.0 (20 - 32) y, 
CARDIA Study 
Mirror tracing 
and video game 
SBP, DBP 5 y Increase in resting 
SBP, DBP ≥ 8 
mmHg, 
hypertensive status 
SBP reactivity to video 
game at baseline 
predicted increase in 
resting SBP (≥ 8 
mmHg) in men only;  
In black men only, 
new hypertensives 
had a greater DBP 
reactivity to video 
game at baseline than 
normotensives 
(2) 
SBP reactivity to video 
game at baseline did 
not predict increase in 
resting SBP (≥ 8 
mmHg) in women; 
DBP reactivity to 
video game did not 
predict increase in 
resting DBP (≥ 8 
mmHg); 
SBP, DBP reactivity to 
mirror tracing did not 
predict increase in 
resting SBP, DBP (≥ 8 
mmHg); 
3, 4, 4, 4, 3, n 
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SBP reactivity to video 
game or mirror 
tracing did not differ 
between new 
hypertensives and 
normotensives for any 
race/gender group; 
In women and white 
men, DBP reactivity to 
video game did not 
differ between new 
hypertensives and 
normotensives; 
DBP reactivity to 
mirror tracing did not 
differ between new 
hypertensives and 
normotensives for any 
race/gender group 
(19) 




44.1 ± 5.9 y, 
Whitehall II 
Mental stress task 
(Raven's 
matrices) 
SBP, DBP 10.8 ± 0.5 y Resting SBP, DBP, 
hypertensive status  
SBP reactivity at 
baseline predicted 
resting SBP at follow-
up 
(1) 
SBP, DBP reactivity at 
baseline did not 
predict resting DBP at 
follow-up; 
SBP, DBP reactivity at 
baseline did not 
predict hypertensive 
status at follow-up 
(after adjustment for 
covariates; p=0.07 for 
DBP reactivity) 
(4) 
4, 3, 4, 3, 3, n 
10 Stewart and 
France (2001) 
USA 
43 F, 30 M,  
18 - 20 y 
Mental arithmetic SBP, DBP, HR 3 y Resting SBP, DBP HR reactivity at 
baseline predicted 
resting SBP at follow-
up 
(1) 
SBP, DBP reactivity at 
baseline did not 
predict resting SBP at 
follow-up; 
SBP, DBP, HR 
reactivity at baseline 
did not predict resting 
DBP at follow-up 
3, 4, 3, 4, 2, n 
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(5) 
11 Carroll et al. 
(2003) 
Scotland 
541 F, 449 M, 
41.7 ± 14.8 y, 
West of Scotland 
Twenty-07 Study 
PASAT SBP, DBP 5.1 ± 0.5 y Resting SBP, DBP SBP reactivity at 
baseline predicted 
resting SBP at follow-
up; 
SBP, DBP reactivity at 
baseline predicted 5-y 
upward drift in resting 
SBP, DBP, respectively 
(3) 
DBP reactivity at 
baseline was not 
associated with 
resting DBP at follow-
up 
(1) 
4, 3, 4, 4, 3, n 
12 Fauvel et al. 
(2003) 
France 
292 F&M for 
progression to 
hypertension, 
286 F&M for end 
of follow-up (1-
5-y) resting SBP, 
DBP, 
131 F&M for 5-y 
ambulatory SBP, 
DBP, 
38 (18 - 55) y 
Stroop task SBP, DBP, HR Annual 
check-up for 
up to 5.0 (1-
6) y  
Progression to 
hypertension 
assessed at annual 
check-up, 
end of follow-up (1-




(0) Progression to 





End of follow-up (1-5-
y) resting SBP, DBP did 




5-y ambulatory SBP, 





No results were 
reported for DBP or 
HR reactivity 
(5) 
3, 4, 4, 4, 3, n 
13 Jennings et al. 
(2004) 
Finland 
756 M,  







and Stroop tasks 
SBP, DBP, HR 7 y Carotid intima-
media thickness 
(IMT) 
SBP reactivity at 
baseline predicted 
progression of mean 
carotid IMT, maximal 
carotid IMT and 
plaque height from 
baseline to follow-up 
(3) 
DBP, HR reactivity at 
baseline did not 
predict IMT measures 
at follow-up 
(6) 
4, 4, 4, 4, 4, n 
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and video game 
SBP, DBP 3, 5, 8 and 
13 y 
Time to occurrence 
of hypertension 
SBP reactivity to 
mirror tracing and 
video game at 
baseline predicted 
earlier onset of 
hypertension; 
DBP reactivity to 
mirror tracing at 
baseline predicted 
earlier onset of 
hypertension; 
DBP reactivity to 
video game at 
baseline predicted 
earlier onset of 
hypertension in men 
(4) 
DBP reactivity to 
video game at 
baseline did not 
predict earlier onset 
of hypertension in 
women 
(1) 
4, 4, 4, 4, 4, n 




51.9 ± 2.9 y, 
85 M, 
52.6 ± 2.5 y, 
Whitehall II 





SBP, DBP 3.1 ± 0.3 y Ambulatory SBP, 
DBP 
SBP reactivity at 
baseline predicted 
ambulatory SBP at 
follow-up 
(1) 
DBP reactivity at 
baseline did not 
predict ambulatory 
DBP at follow-up 
(1) 
4, 4, 4, 4, 4, n 
16 Steptoe and 
Marmot (2005) 
England 
98 F,  
51.8 ± 2.8 y, 
111 M,  
52.6 ± 2.6 y, 
Whitehall II 





SBP, DBP, HR 3.1 ± 0.3 y Resting SBP, DBP (0) SBP, DBP, HR 
reactivity at baseline 
did not predict resting 
SBP or DBP at follow-
up after adjustment 
for post-stress 
recovery values 
(measured 40–45 min 
after stress) 
(6) 
4, 2, 4, 4, 4, n 
17 Steptoe and 
Wardle (2005) 
England 
96 F,  
51.7 ± 2.7 y, 
110 M,  
52.7 ± 2.7 y, 
Whitehall II 





SBP, DBP, HR 3.0 y BMI, WHR change 
across 3 y 
(0) There was no 
significant change in 
BMI across the 3 y 
(SBP, DBP, HR 
reactivity at baseline 
did not predict BMI 
change); 
4, 4, 4, 4, 4, p 
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No results are 
reported for SBP, DBP, 
HR reactivity at 
baseline and WHR 
change (only post-
stress recovery results 
are reported) 
(3) 













SBP, DBP, HR 4.8 y Ambulatory SBP, 
DBP 
SBP, DBP reactivity at 
baseline predicted 
ambulatory DBP at 
follow-up 
(2) 
SBP, DBP reactivity at 
baseline did not 
predict ambulatory 
SBP at follow-up; 
No results are 
reported for HR 
reactivity 
(2) 
4, 4, 4, 4, 4, n 








and video game  
SBP, DBP, HR 13 y Coronary artery 
calcification (CAC) 
SBP reactivity to video 
game at baseline 
predicted CAC at 
follow-up; 
Blunted HR reactivity 
to video game at 
baseline predicted 
CAC at follow-up in 
blacks 
(2) 
DBP reactivity to 
video game at 
baseline did not 
predict CAC at follow-
up; 
Blunted HR reactivity 
to video game at 
baseline did not 
predict CAC at follow-
up in whites; 
SBP, DBP, HR 
reactivity to mirror 
tracing at baseline did 
not predict CAC at 
follow-up 
(5) 
4, 4, 3, 4, 3, n 
20 Stewart et al. 
(2006) 
USA 
110 F, 106 M,  











SBP, DBP, HR 3.2 (2.3-4.3) 
y 
Resting SBP, DBP (0) Resting SBP, DBP 
decreased 
significantly from 
baseline to follow-up 
(SBP, DBP, HR 
reactivity at baseline 
did not predict change 
in resting SBP, DBP 
3, 3, 4, 4, 3, n  




from baseline to 
follow-up)  
(6) 
21 Heponiemi et al. 
(2007) 
Finland 
33 F, 33 M,  
28.5 ± 4.7 yh, 
Cardiovascular 








HR 2.0 – 2.5 y Carotid IMT Blunted HR reactivity 
at baseline predicted 
greater carotid IMT at 
follow-up 
(1) 
(0) 4, 4, 2, 3, 3, n 




41.8 ± 15.4 y, 
West of Scotland 
Twenty-07 Study 
PASAT SBP, DBP, HR 5.5 ± 1.0 y BMI, WHR, obesity 
(BMI ≥ 30kg/m2) 
Blunted HR reactivity 
at baseline predicted 
increased likelihood of 
being obese at follow-
up 
(1) 
SBP, DBP, HR 
reactivity at baseline 
did not predict 
increase in BMI or 
WHR from baseline to 
follow-up; 
No results are 
reported for SBP, DBP 
reactivity at baseline 
and likelihood of 
being obese at follow-
up 
(6) 
3, 4, 4, 4, 3, n 




19.3 ± 0.4 y, 
Military draft 
screening 
Mental arithmetic Arterial A, NA 18.0 ± 0.9 y Fasting glucose, 
HOMA-IR 
(0) A, NA reactivity at 
baseline did not 
predict fasting glucose 
or HOMA-IR at follow-
up 
(4) 
4, 4, 3, 4, 4, n 




19.3 ± 0.4 y, 
Military draft 
screening 
Mental arithmetic SBP, DBP, HR, 
arterial A, NA 
18.0 ± 0.9 y Resting SBP, DBP When resting SBP was 
adjusted for, absolute 




absolute levels of A 
negatively predicted 
resting SBP at follow-
up; 
When resting DBP was 
adjusted for, absolute 
SBP, DBP, HR, A, NA 
reactivity at baseline 
did not predict resting 
SBP, DBP at follow-up 
(10) 
3, 4, 2, 4, 4, n 
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levels of DBP during 
mental arithmetic 
positively predicted 
and absolute levels of 
A negatively predicted 
resting DBP at follow-
up 
(5) 
25 Flaa et al. (2008c) 
Norway 
80 M, 
19.3 ± 0.4 y, 
Military draft 
screening 
















NA reactivity at 
baseline was a near 
significant predictor of 
BMI (P=0.08) and 
triceps skinfold 
thickness (P=0.08) at 
follow-up 
(2) 
4, 3, 4, 4, 4, n 




41.8 ± 15.4 y, 
West of Scotland 
Twenty-07 Study 
PASAT SBP, DBP, HR 5.5 ± 1.0 y Self-reported 
health 
Blunted DBP, HR 
reactivity at baseline 
predicted poorer self-
reported health at 
follow-up 
(2) 
SBP reactivity at 
baseline did not 
predict self-reported 
health at follow-up 
(1) 
3, 3, 4, 4, 3, n 
27 Carroll et al. 
(2011)i 
Scotland 
645 F, 551 M,  
40.7 ± 14.8 y, 




PASAT SBP, DBP 12.4 ± 0.4 y Resting SBP, DBP, 
upward drift in SBP, 
DBP, hypertensive 
status 
SBP reactivity at 
baseline predicted 
resting SBP, upward 
drift in SBP and risk of 
being hypertensive at 
follow-up 
(3) 
DBP reactivity at 
baseline did not 
predict resting DBP 
(P=0.06), upward drift 
in DBP (P=0.06) or risk 
of being hypertensive 
at follow-up 
(3) 
3, 4, 4, 4, 4, n 
28 Ginty et al. 
(2011) 
Scotland 
618 - 677 F, 
529 - 574 M, 
42.2 ± 15.4 y, 
West of Scotland 
Twenty-07 Study 
PASAT SBP, DBP, HR 5.5 ± 1.0 y, 





Blunted HR reactivity 
at baseline predicted 
lower general 
intelligence scores 
and slower choice 
reaction times at 5- 
SBP, DBP reactivity at 
baseline did not 
predict general 
intelligence scores at 
5- or 12-y follow-up, 
choice reaction time 
3, 3, 3, 4, 3, n 
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and 12-y follow-up 
and greater decline 
between assessments 
for both measures; 
Blunted SBP reactivity 
predicted slower 
choice reaction times 
at 5-y follow-up  
(7) 
at 12-y follow-up or 
decline of either 
measure between 
assessments; 
DBP reactivity at 
baseline did not 
predict choice 
reaction time at 5-y 
follow-up 
(11) 
29 Phillips et al. 
(2011a) 
Scotland 
459 F, 393 M,  
51.9 ± 9.4 y, 
West of Scotland 
Twenty-07 Study 









Blunted HR reactivity 
at baseline predicted 
greater deterioration 
of physical function 
over 5 y of follow-up 
(1) 
SBP, DBP reactivity at 
baseline did not 
predict change in 
disability score 
(2) 
3, 4, 4, 4, 3, n 
30 Phillips et al. 
(2011b) 
Scotland 
686 F, 559 M,  
42.3 ± 15.5 y, 
West of Scotland 
Twenty-07 Study 
PASAT SBP, DBP, HR 5.5 ± 1.0 y Depression, anxiety 
symptoms 
Blunted HR reactivity 





HR reactivity at 
baseline did not 
predict anxiety 
symptoms at follow 
up (after adjustment 
for covariates); 
SBP, DBP reactivity at 
baseline did not 
predict depression or 
anxiety symptoms at 
follow-up 
(5) 
3, 4, 4, 4, 3, n 
31 Hamer and 
Steptoe (2012) 
England 
222 F, 257 M,  
62.7 ± 5.6 y, 
Whitehall II 




random order, as 
one stressor) 
Salivary cortisol 
(0, 10, 30, 55, 
85 min; change 
score and AUCi) 





reactivity at baseline 
(both change score 
and AUCi)  predicted 
risk of hypertension at 
follow-up 
(1) 
(0) 3, 4, 4, 4, 4, n 
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32 Hamer et al. 
(2012) 
England 
213 F, 253 M,  
62.7 ± 5.6 y, 
Whitehall II 
 








(0, 10, 30, 55, 
85 min; change 
score) 
3.0 (1.8 - 
3.6) y 
Risk of CAC 
progression, 
relative CAC change 
Salivary cortisol 
reactivity at baseline 
predicted risk of CAC 
progression and 
relative CAC change  
(2) 
SBP, DBP reactivity at 
baseline did not 
predict risk of CAC 
progression   
(2) 
3, 4, 4, 4, 4, n 
33 Phillips et al. 
(2012) 
The Netherlands 
240 F, 220 M, 








SBP, DBP, HR, 
salivary cortisol 
(-15, 0, 11, 22, 
37, 47, 57 min; 
change score) 
4 – 7 y BMI, obesity (BMI ≥ 
30kg/m2) 
Blunted HR reactivity 
at baseline predicted 
increased risk of 
becoming or 
remaining obese 
between baseline and 
follow-up 
(1) 
SBP, DBP, cortisol 
reactivity at baseline 
did not predict change 
in BMI; 
Results for other 
exposure/outcome 
combinations are not 
reported 
(3) 
4, 1, 4, 4, 2, n 
34 Shaffer et al. 
(2012) 
Canada 
719 - 724 F, 
743 - 746 M, 







SBP, DBP 10 y Fatal or nonfatal 
incident CVD 
events  
(0) SBP, DBP reactivity at 
baseline did not 
predict risk of incident 
CVD events during 10 
y of follow-up 
(2) 
1, 3, 3, 4, 3, n 
35 Senan and 
Petrosyan (2014) 
India 
86 F, 260 M,  




HR Up to 7 y Sudden coronary 
death, non-sudden 
coronary death, 
death from any 
cause 
HR reactivity at 
baseline predicted risk 
for sudden coronary 
death and death from 
any cause during the 7 
y of follow-up 
(2) 
HR reactivity at 
baseline did not 
predict risk for non-
sudden coronary 
death during the 7 y 
of follow-up 
(1) 
1, 2, 3, 1, 1, p 
36 Gentile et al. 
(2015) 
Canada 
81 F, 55 M,  





A neutral reading 
task, two role 










were in highest 
quartile (lowest for 
HDL)), risk of having 
metabolic 
syndrome 
(0) SBP, DBP, HR 
reactivity at baseline 
did not predict 
metabolic burden or 




3, 4, 4, 4, 3, n 
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37 Paananen et al. 
(2015) 
Australia 
198 – 222 F, 
198 – 215 M, 






TSST Plasma total 
cortisol (0, 15, 
25, 35, 45, 60, 
75, 105 min; 
cluster analysis) 
4 y Musculoskeletal 
pain alone (any 
pain, high pain), 
musculoskeletal 
pain combined with 
increased 
sensitivity to cold, 
pressure pain 
Blunted plasma 
cortisol reactivity at 
baseline predicted 
greater likelihood of 
musculoskeletal pain 
(any pain, high pain) 
in females with 
greater sensitivity to 
cold pain; 
Blunted plasma 
cortisol reactivity at 
baseline predicted 
greater likelihood of 
high musculoskeletal 
pain in females with 




reactivity at baseline 
did not predict 
musculoskeletal pain 
alone in females or 
any musculoskeletal 
pain in females with 
greater sensitivity to 
pressure pain; 
Plasma cortisol 
reactivity at baseline 
did not predict any 
musculoskeletal pain 
outcomes in males 
(9) 
3, 4, 1, 4, 3, n 
38 Steudte-














TSST Salivary cortisol 























cortisol reactivity at 
baseline predicted a 
greater increase in 
PTSD symptomatology 





(0) 3, 4, 4, 2, 2, n 
39 Yuenyongchaiwat 
et al. (2015) 
Thailand 
75 F, 26 M, 
31.3 ± 9.5 y 
Mental arithmetic 
and speech tasks 
SBP, DBP, HR 1.1 (1.0 – 
1.3) y 
Resting SBP, DBP SBP reactivity to 
mental arithmetic at 
baseline predicted 
resting SBP at follow 
up 
(1) 
SBP, DBP, HR 
reactivity at baseline 
did not predict resting 
DBP at follow-up; 
Results for other 
exposure/outcome 
combinations are not 
reported 
(3) 
4, 4, 3, 4, 4, n 
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40 Brindle et al. 
(2016) 
The Netherlands 
230 F, 208 M, 








SBP, DBP, HR 
(cluster analysis 
was used) 
5.5 ± 0.6 y Hypertensive status Membership of a 




reactivity at baseline 
predicted greater risk 




clusters with high 
reactivity of SBP, DBP 
& HR or low reactivity 
of SBP, DBP & HR at 
baseline did not 




4, 3, 3, 4, 3, n 
41 Ronaldson et al. 
(2016) 
England 
84 F, 37 M, 
63.5 ± 5.7 y 
Whitehall II 




random order, as 
one stressor) 
Salivary cortisol 
(0, 10, 30, 55, 
85 min; change 
score) 
3 y Regulatory T cell 
percentage, 







cortisol reactivity at 
baseline predicted 
greater regulatory T 
cell and lower 
responder T cell 
percentage at follow-
up; 
In turn, higher 
regulatory T cell 
percentage was 
associated with worse 
physical and mental 




(0) 3, 4, 1, 4, 3, n 
42 Steptoe et al. 
(2016) 
England 
299 F, 307 M, 
59.1 ± 6.7 y, 
Whitehall II 





SBP, DBP 7.9 ± 3.4 y Incident 
hypertension 
SBP, DBP reactivity at 
baseline predicted risk 
of hypertension at 
follow-up 
(2) 
(0) 4, 3, 4, 4, 4, n 
43 Yuichiro et al. 
(2016) 
USA 
1698 F, 1323 M 
27.1 ± 3.6 y, 
CARDIA Study 
Mirror tracing 
and video game 





Blunted SBP reactivity 
to mirror tracing and 
video game at 
baseline predicted 
worse psychomotor 
speed and executive 
function at follow-up; 
SBP reactivity at 
baseline did not 
predict verbal 
memory at follow-up; 
DBP reactivity to 
mirror tracing at 
baseline did not 
predict verbal 
4, 4, 1, 4, 4, n 
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Blunted DBP reactivity 
to mirror tracing at 
baseline predicted 
worse psychomotor 
speed at follow-up; 
Blunted DBP reactivity 
to video game at 
baseline predicted 
worse verbal memory 
at follow-up 
(6) 
memory or executive 
function at follow-up; 
DBP reactivity to the 
video game did not 
predict psychomotor 
speed or executive 
function at follow-up 
(6) 
44 Zhu et al. (2016) 
Australia 
390 F, 411 M for 
salivary cortisol, 
291 F, 357 M for 
plasma cortisol, 






TSST Salivary cortisol 
(0, 15, 35, 105 
min; AUCi) and 
total plasma 
cortisol (0, 15, 
25, 35, 45, 60, 
75, 105 min; 
AUCi) 
2 y Total body bone 
mineral content 




cortisol reactivity at 
baseline predicted 
lower BMD, BMC at 
follow-up in males 
(2) 
Salivary cortisol 
reactivity at baseline 
did not predict BMD, 
BMC at follow-up in 
females or bone area 
at follow-up in either 
sex; 
Total plasma cortisol 
reactivity at baseline 
did not predict any 
bone outcomes at 
follow-up 
(10) 
3, 4, 1, 4, 3, n 
45 Steptoe et al. 
(2017) 
England 
215 F, 196 M, 
54 - 76 y 
Whitehall II 




random order, as 
one stressor) 
Salivary cortisol 
(0, 10, 30, 55, 
85 min; change 
score) 
3 y Leukocyte telomere 
length 
Salivary cortisol 
reactivity at baseline 
predicted shorter 
telomere length at 
follow-up 
(1) 




74 F, 21 M, 





and speech tasks 
SBP, DBP, HR 3.4 ± 0.1 y Resting SBP, DBP SBP reactivity to 
mental arithmetic at 
baseline predicted 
resting SBP at follow-
up 
(1) 
SBP reactivity to 
speech task at 
baseline did not 
predict resting SBP at 
follow-up; 
DBP reactivity at 
baseline did not 
predict resting DBP at 
follow-up; 
4, 4, 3, 4, 4, n 
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Results for other 
exposure/outcome 







75 F, 27 M, 
31.9 ± 10.0 yh 
Mental arithmetic 
and speech tasks 




Blunted SBP reactivity 
to mental arithmetic 
at baseline predicted 
anxiety symptoms at 
follow-up 
(1) 
SBP reactivity to 
speech task did not 
predict anxiety at 
follow-up; 
DBP, HR reactivity at 
baseline did not 
predict anxiety at 
follow-up; 
SBP, DBP, HR 
reactivity at baseline 




4, 4, 4, 4, 4, n 
Data are presented as mean ± SD or mean (range) or mean or range; F = female; M = male; y = years; SBP = systolic blood pressure; DBP = diastolic blood pressure; MAP = 
mean arterial pressure; HR = heart rate; IMT = intima-media thickness; BMI = body mass index; CAC = coronary artery calcification; PASAT = paced auditory serial addition 
test; WHR = waist-hip ratio; A = adrenaline; NA = noradrenaline; HOMA-IR = homeostasis model assessment of insulin resistance; CVD = cardiovascular disease; TSST = Trier 
Social Stress Test; Stroop task = Stroop colour–word interference task; Mirror tracing = Mirror image star-tracing task; PTSD = Post Traumatic Stress Disorder 
a N is reported as the number of participants who were included in the final longitudinal analysis, not the number who entered the study or the number who may have 
been included in concurrent cross-sectional, or other, analyses, if applicable. Age is reported as mean, range or mean±SD, where available. 
b Only stressors included in the final analysis are included here. Where studies imposed both physical and psychological stressors, only the psychological stressors are 
included in this systematic review. 
c Includes sample timing and method of reactivity calculation for cortisol. Time = 0 minutes indicates the commencement of the stressor(s). 
d Study quality and risk of bias assessment utilised the following questions and answer codes: 
i) Can we be confident in the assessment of exposure? 
ii) Can we be confident in the assessment of outcome? 
iii) Can we be confident that the outcome of interest was not present at start of study? 
iv) Can we be confident in the assessment of the presence or absence of relevant confounders? 
v) Was the follow up of cohorts adequate? 
vi) Was there evidence of any other sources of bias in reporting? 
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4 = Definitely yes (low risk of bias); 3 = Probably yes; 2 = Probably no; 1 = Definitely no (high risk of bias); n = no; p = possibly 
e This paper also did measurements of pain at baseline but does not indicate when this occurred in relation to when stress testing occurred, therefore, it is not clear if pain 
testing interfered with stress reactivity testing. 
f This was a 4-y follow-up of the same cohort that was earlier followed-up at 1.6 y (Brody and Rau, 1994) 
g This was a 10.8-y follow-up of the same cohort that was earlier followed-up at 4.9 y (Carroll et al., 1995) 
h Age at baseline of study sample calculated as age at follow-up minus follow-up length. 
i This was a 12-y follow-up of the same cohort that was earlier followed-up at 5 y (Carroll et al., 2003). 
j This was a 3.4-y follow-up of the same cohort that was earlier followed-up at 1.1 y (Yuenyongchaiwat et al., 2015).  
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Table 2. Stress reactivity at baselinea and its relationship to health and disease outcomes at follow-up: Synthesis of main significant findingsb 
 SAM system reactivity HPA axis reactivity 
 
Exaggerated SAM system reactivity  
• (SBP, DBP, HR) Greater resting SBP, DBP (2; 3; 5; 8; 
9; 10; 11; 24; 27; 39; 46) 
• (SBP, DBP) Greater ambulatory SBP, DBP (15; 18) 
• (SBP, DBP) Greater risk of hypertension (7; 27; 40; 
42) 
• (SBP, DBP) Earlier onset of hypertension (14) 
• (SBP) Greater progression of IMT (13) 
• (SBP) Greater odds of having CAC (19) 
• (NA) Greater waist circumference (25) 
• (HR) Increased risk for sudden coronary death 
and death from any cause (35) 
Exaggerated HPA axis reactivity 
• (SC) Greater risk of hypertension (31) 
• (SC) Greater CAC progression (32) 
• (SC) More rapid telomere attrition (45) 
 
 
Blunted SAM system reactivity  
• (SBP) Greater illness frequency (1) 
• (HR) Greater increases in resting DBP (4) 
• (HR) Greater odds of having CAC in blacks (but 
not whites) (19) 
• (HR) Greater carotid IMT (21) 
• (A) Greater BMI, waist circumference and 
triceps skinfold thickness (25) 
• (HR) Increased likelihood of being obese (22; 33) 
• (DBP, HR) Poorer self-reported health (26) 
• (HR) Greater progression of self-reported 
physical disability (29) 
• (HR) More depression symptoms (30) 
• (HR, SBP, DBP) Reduced cognitive ability (28; 43) 
• (SBP) More anxiety symptoms (47) 
Blunted HPA axis reactivity 
• (PC) Greater musculoskeletal pain in pain-
sensitive individuals in females (but not males) (37) 
• (SC) More PTSD symptomology after exposure to 
new-onset traumatic events (38) 
• (SC) Greater regulatory T-Cell percentage (which 
in turn, was associated with poorer physical and 
mental health and more depressive 
symptomatology) (41) 
• (SC) Lower bone mineral content and bone 
mineral density in males (but not females) (44) 
 
SAM system = sympatho-adrenal medullary system; HPA axis = hypothalamo-pituitary adrenal axis; SBP = systolic blood pressure; DBP = diastolic blood pressure; HR = heart 
rate; NA = noradrenaline; A = adrenaline; SC = salivary cortisol; PC = plasma cortisol; IMT = intima-media thickness; CAC = coronary artery calcification; BMI = body mass 
index; * acute psychological stress 
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a Stress reactivity variables measured at baseline are indicated in parentheses ahead of each outcome measured at follow-up.  
b Superscript numbers refer to study numbers defined in Table 1. 
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